USNA 📈 USANA Health Sciences - Overview
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US90328M1071
USNA: Vitamins, Minerals, Supplements, Skincare, Meal Replacement, Snack Bars
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah. Web URL: https://www.usana.com
Additional Sources for USNA Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
USNA Stock Overview
| Market Cap in USD | 636m |
| Sector | Consumer Defensive |
| Industry | Packaged Foods |
| GiC Sub-Industry | Personal Care Products |
| IPO / Inception | 1996-07-25 |
USNA Stock Ratings
| Growth 5y | -85.4% |
| Fundamental | 11.8% |
| Dividend | - |
| Rel. Strength Industry | -343 |
| Analysts | 3/5 |
| Fair Price Momentum | 25.40 USD |
| Fair Price DCF | 89.09 USD |
USNA Dividends
No Dividends PaidUSNA Growth Ratios
| Growth Correlation 3m | 28.9% |
| Growth Correlation 12m | -88.8% |
| Growth Correlation 5y | -77.7% |
| CAGR 5y | -15.84% |
| CAGR/Mean DD 5y | -0.51 |
| Sharpe Ratio 12m | -1.31 |
| Alpha | -61.49 |
| Beta | 0.94 |
| Volatility | 42.89% |
| Current Volume | 619.8k |
| Average Volume 20d | 118.3k |
What is the price of USNA stocks?
As of December 22, 2024, the stock is trading at USD 33.38 with a total of 619,780 shares traded.
Over the past week, the price has changed by -7.74%, over one month by -11.09%, over three months by -13.61% and over the past year by -32.93%.
As of December 22, 2024, the stock is trading at USD 33.38 with a total of 619,780 shares traded.
Over the past week, the price has changed by -7.74%, over one month by -11.09%, over three months by -13.61% and over the past year by -32.93%.
Is USANA Health Sciences a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, USANA Health Sciences is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 11.77 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of USNA as of December 2024 is 25.40. This means that USNA is currently overvalued and has a potential downside of -23.91%.
Neither. Based on ValueRay Fundamental Analyses, USANA Health Sciences is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 11.77 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of USNA as of December 2024 is 25.40. This means that USNA is currently overvalued and has a potential downside of -23.91%.
Is USNA a buy, sell or hold?
USANA Health Sciences has received a consensus analysts rating of 3.00. Therefor, it is recommend to hold USNA.
USANA Health Sciences has received a consensus analysts rating of 3.00. Therefor, it is recommend to hold USNA.
- Strong Buy: 0
- Buy: 0
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecast for USNA stock price target?
According to ValueRays Forecast Model, USNA USANA Health Sciences will be worth about 28.2 in December 2025. The stock is currently trading at 33.38. This means that the stock has a potential downside of -15.67%.
According to ValueRays Forecast Model, USNA USANA Health Sciences will be worth about 28.2 in December 2025. The stock is currently trading at 33.38. This means that the stock has a potential downside of -15.67%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 46.5 | 39.3% |
| Analysts Target Price | 68 | 103.7% |
| ValueRay Target Price | 28.2 | -15.7% |